AU2002319989A1 - Heterocyclic amines for the treatment of conditions associated with gsk-3 - Google Patents

Heterocyclic amines for the treatment of conditions associated with gsk-3

Info

Publication number
AU2002319989A1
AU2002319989A1 AU2002319989A AU2002319989A AU2002319989A1 AU 2002319989 A1 AU2002319989 A1 AU 2002319989A1 AU 2002319989 A AU2002319989 A AU 2002319989A AU 2002319989 A AU2002319989 A AU 2002319989A AU 2002319989 A1 AU2002319989 A1 AU 2002319989A1
Authority
AU
Australia
Prior art keywords
gsk
treatment
conditions associated
heterocyclic amines
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002319989A
Inventor
Stefan Berg
Sven Hellberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002319989A1 publication Critical patent/AU2002319989A1/en
Abandoned legal-status Critical Current

Links

AU2002319989A 2001-07-05 2002-07-03 Heterocyclic amines for the treatment of conditions associated with gsk-3 Abandoned AU2002319989A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102438-9 2001-07-05

Publications (1)

Publication Number Publication Date
AU2002319989A1 true AU2002319989A1 (en) 2003-01-21

Family

ID=

Similar Documents

Publication Publication Date Title
IL159347A0 (en) Arylamines for the treatment of conditions associated with gsk-3
AU2003299791A1 (en) Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
PL376454A1 (en) 1-acyl-pyrrolidine derivatives for the treatment of viral infections
EP1638508A4 (en) Shunt for the treatment of glaucoma
AU2003281978A1 (en) 2,5-diketopiperazines for the treatment of obesity
HUP0302719A3 (en) Substituted amine derivatives and their use for the treatment of angiogenesis
AP2005003250A0 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia.
GB0125222D0 (en) Composition for the treatment of microbial infections
SI1231920T1 (en) Use of epinastin for the treatment of allergic rhinitis/conjunctivitis
AU2002356525A1 (en) Substituted amines for the treatment of neurological disorders
AU2002338807A1 (en) Use of c-kit inhibitors for the treatment of myeloma
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
EP1442062A4 (en) Methods for the treatment of carcinoma
PL369850A1 (en) Substituted indoles, method for production and use thereof for the inhibition of pain
IL165773A0 (en) Use of nefopam for the treatment of nausea or emesis
AU2003260882A1 (en) Heterocyclic substituted piperazines for the treatment of schizophrenia
AU2003291886A1 (en) Thiophenederivatives for the treatment of flavivirus infections
PL371524A1 (en) Combination therapy for the treatment of bacterial infections
AU2003258983A8 (en) Combinations for the treatment of fungal infections
HK1080369A1 (en) Epothilone derivatives for the treatment of multiple myeloma
AU2002304883A1 (en) Device for the treatment of tumours
AU2002319989A1 (en) Heterocyclic amines for the treatment of conditions associated with gsk-3
AU2003274885A1 (en) Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders